News
A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with ...
The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...
12h
Clinical Trials Arena on MSNAdicet Bio doses first SSc subject in second cohort of trial evaluating ADI-001Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.
Mizzou scientist discovers how a deadly bacterium spread by the lone star tick survives, bringing hope for new treatments.
TCG Labs Soleil, which launched in 2024 in collaboration with The Column Group, is focused on building single-drug biotechs ...
TCG Labs Soleil has secured $400 million to boost the firm’s ability to advance its biotech portfolio companies while also expanding its R&D capabilities globally. | TCG Labs Soleil has secured $400 ...
Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...
A new online tool developed by researchers at the University of Louisville promises to speed up the discovery of treatments for brain and nerve tumors, especially rare ones that have had limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results